J. Alexander Bodkin, MD
Director of the Clinical Psychopharmacology Research Program at McLean Hospital in Belmont, MA; assistant professor of psychiatry at Harvard Medical School
Dr. Bodkin has disclosed that he has been a principal investigator in a study of brexpiprazole. Dr. Carlat has reviewed his interview and has found no evidence of bias in this educational activity.
Dr. Bodkin discusses methods for approaching treatment resistant depression and his perspective on depressive illness as a final common pathway for a number of different brain problems.
Viibryd has gone generic, but is it worth prescribing? We review all there is to know about vilazodone in this update from our #1 most read article of 2023.